In Hiroshima, Tresiba (Insulin Degludec) Effect and Safety in Diabetes study
Phase of Trial: Phase II
Latest Information Update: 05 Jul 2017
Price : $35 *
At a glance
- Drugs Insulin degludec (Primary)
- Indications Diabetes mellitus
- Focus Therapeutic Use
- 03 Jul 2017 Status changed from active, no longer recruiting to completed.
- 25 Dec 2014 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 05 Jul 2013 New trial record